New Jersey Hematology Oncology Associates is a clinical research site located in Brick, New Jersey, United States 08724-3009.
Crixeo Clinical Trials Trust Score: 20/100 (FAILING). This profile has not yet been claimed by the site owner.
New Jersey Hematology Oncology Associates has participated in 18 clinical trials with 1 currently active.
Therapeutic areas: Myelofibrosis, Polycythemia Vera, Thrombocythemia.
Sponsors: Incyte Corporation, Takeda, KangLaiTe USA.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in New Jersey · View every site in Brick
Trust Score: 20/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
New Jersey Hematology Oncology Associates has a Crixeo Trust Score of 20/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
New Jersey Hematology Oncology Associates has 18 clinical trials on record, with 1 currently active. Their work covers Myelofibrosis, Polycythemia Vera, Thrombocythemia.
New Jersey Hematology Oncology Associates has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.